NCT07783971

Brief Summary

This study aims to uncover the characteristics of the fungal flora in non-small cell lung cancer, and to investigate the relationship between pulmonary fungi and the various pathological subtypes, stages, clinical features of non-small cell lung cancer, as well as patient prognosis. It seeks to provide new perspectives for a comprehensive understanding of non-small cell lung cancer, as well as new approaches for its early diagnosis and prognosis assessment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
23mo left

Started Aug 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Aug 2026Aug 2028

First Submitted

Initial submission to the registry

August 1, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
24 days until next milestone

First Posted

Study publicly available on registry

August 25, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

August 25, 2026

Status Verified

August 1, 2026

Enrollment Period

1.5 years

First QC Date

August 1, 2026

Last Update Submit

August 21, 2026

Conditions

Keywords

the lung microbiome

Outcome Measures

Primary Outcomes (1)

  • the fungal microbial environment

    Different fungal microbial environments were observed in different parts of lung tissue.

    baseline, pre-surgery

Study Arms (2)

Lung cancer group

The samples included in this group were lung cancer tissues.

Normal lung tissue group

The samples included in this group were normal lung tissues.

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The research object is the patients who are newly diagnosed as "non-small cell lung cancer" and intend to undergo surgical resection

You may qualify if:

  • Non-small cell lung cancer was diagnosed by biopsy before operation, frozen pathology during operation or paraffin section after operation; The patients were 30 to 80 years old; No chemotherapy, radiotherapy, targeted therapy or immunotherapy were given before operation;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

958th Army Hospital

Chongqing, Liangjiang New, 400020, China

RECRUITING

Related Publications (3)

  • Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, Iliev ID. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022 Sep 29;185(20):3807-3822.e12. doi: 10.1016/j.cell.2022.09.015.

    PMID: 36179671BACKGROUND
  • Liu NN, Yi CX, Wei LQ, Zhou JA, Jiang T, Hu CC, Wang L, Wang YY, Zou Y, Zhao YK, Zhang LL, Nie YT, Zhu YJ, Yi XY, Zeng LB, Li JQ, Huang XT, Ji HB, Kozlakidis Z, Zhong L, Heeschen C, Zheng XQ, Chen C, Zhang P, Wang H. The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells. Cancer Cell. 2023 Nov 13;41(11):1927-1944.e9. doi: 10.1016/j.ccell.2023.08.012. Epub 2023 Sep 21.

    PMID: 37738973BACKGROUND
  • Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D, Gavert N, Stajich JE, Amit G, Gonzalez A, Wandro S, Perry G, Ariel R, Meltser A, Shaffer JP, Zhu Q, Balint-Lahat N, Barshack I, Dadiani M, Gal-Yam EN, Patel SP, Bashan A, Swafford AD, Pilpel Y, Knight R, Straussman R. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. 2022 Sep 29;185(20):3789-3806.e17. doi: 10.1016/j.cell.2022.09.005.

    PMID: 36179670BACKGROUND

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Lung tissue

MeSH Terms

Conditions

MycosesLung NeoplasmsCarcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Bacterial Infections and MycosesInfectionsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesCarcinoma, BronchogenicBronchial Neoplasms

Central Study Contacts

shunhong wang project leader

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident physician

Study Record Dates

First Submitted

August 1, 2026

First Posted

August 25, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

January 30, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

August 25, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Study Protocol (The project has been put on re)Access

Locations